Suppr超能文献

早产胎膜早破的封闭治疗程序

Sealing procedures for preterm prelabour rupture of membranes.

作者信息

Crowley Adele E, Grivell Rosalie M, Dodd Jodie M

机构信息

Department of Obstetrics and Gynaecology, The Women's and Children's Hospital, 72 King William Road, Adelaide, South Australia, Australia, 5006.

出版信息

Cochrane Database Syst Rev. 2016 Jul 7;7(7):CD010218. doi: 10.1002/14651858.CD010218.pub2.

Abstract

BACKGROUND

Preterm prelabour rupture of the membranes (PPROM) complicates approximately 2% of pregnancies and can be either spontaneous or iatrogenic in nature. Complications of PPROM include prematurity, chorioamnionitis, neonatal sepsis, limb position defects, respiratory distress syndrome, pulmonary hypoplasia chronic lung disease, periventricular leukomalacia and intraventricular haemorrhage.A number of different sealing techniques have been employed which aim to restore a physical barrier against infection and encourage the re-accumulation of amniotic fluid. Routine use of sealants is currently not recommended due to a lack of sufficient evidence to support the safety and effectiveness of such interventions.

OBJECTIVES

To assess the effects of sealing techniques following PPROM against each other, or versus standard care (including no sealant), on maternal and neonatal outcomes.

SEARCH METHODS

We searched the Cochrane Pregnancy and Childbirth Group's Trials Register (30 May 2016) and reference lists of retrieved studies.

SELECTION CRITERIA

Randomised and quasi-randomised controlled trials comparing different techniques for sealing preterm prelabour ruptured membranes. Cluster-randomised trials and trials using a cross-over design were not eligible for inclusion in this review. We planned to include abstracts when sufficient information was provided.

DATA COLLECTION AND ANALYSIS

Two review authors independently assessed trials for inclusion and assessed trial quality. Two review authors independently extracted data. Data were checked for accuracy.

MAIN RESULTS

We included two studies (involving 141 women - with data from 124 women). We considered both studies as being at high risk of bias. Meta-analysis was not possible because the included studies examined different interventions (both in comparison with standard care) and reported on few, but different, outcomes. One study compared cervical adapter (mechanical sealing), and the other study examined an immunological membrane sealant. Neither of the included studies reported on this review's primary outcome of interest - perinatal mortality. Similarly, data were not reported for the majority of this review's secondary infant and maternal outcomes. Cervical adapter (mechanical sealing) versus standard care (one study, data from 35 participants)No data were reported for this review's primary outcome - perinatal mortality. Data were reported for few of this review's infant or maternal secondary outcomes.There was no clear difference between the mechanical sealing group and the standard care control in relation to the incidence of neonatal sepsis (risk ratio (RR) 1.19, 95% confidence interval (CI) 0.28 to 5.09 (very low-quality evidence)) or chorioamnionitis (RR 1.19, 95% CI 0.28 to 5.09 (very low-quality evidence)). Oral immunological membrane sealant versus standard care (one study, data from 94 participants)No data were available for perinatal mortality (this review's primary outcome) or for the majority of this review's infant and maternal secondary outcomes. Compared to standard care, the immunological membrane sealant was associated with a reduction in preterm birth less than 37 weeks (RR 0.48, 95% CI 0.34 to 0.68 (very low-quality evidence)) and a reduction in neonatal death (RR 0.38, 95% CI 0.19 to 0.75 (very low-quality evidence)). However, there was no clear difference between groups in terms of neonatal sepsis (RR 0.64, 95% CI 0.28 to 1.46 (very low-quality evidence)) or respiratory distress syndrome (RR 0.64, 95% CI 0.28 to 1.46 (very low-quality evidence)).

AUTHORS' CONCLUSIONS: There is insufficient evidence to evaluate sealing procedures for PPROM. There were no data relating to this review's primary outcome (perinatal mortality) and the majority of our infant and maternal secondary outcomes were not reported in the two included studies.There was limited evidence to suggest that an immunological membrane sealant was associated with a reduction in preterm birth at less than 37 weeks and neonatal death, but these results should be interpreted with caution as this is based on one small study, with a high risk of bias, and the intervention has not been tested in other studies.Although midtrimester PPROM is not a rare occurrence, there are only a small amount of published data addressing the benefits and risks of sealing procedures. Most of these studies are retrospective and cohort based and could therefore not be included in our data-analysis.This review highlights the paucity of prospective randomised trials in this area. Current evidence provides limited information both on effectiveness and safety for the interventions described. Given the paucity of high-quality data, we recommend that future research efforts focus on the conduct of randomised trials assessing the effect of promising interventions that have been only evaluated to date in cohort studies (e.g. amniopatch). Future trials should address outcomes including perinatal mortality, preterm birth, neonatal death, respiratory distress syndrome, neonatal sepsis and developmental delay. They should also evaluate maternal outcomes including sepsis, mode of delivery, length of hospital stay and emotional well-being.

摘要

背景

胎膜早破(PPROM)约使2%的妊娠复杂化,其本质上可能是自发的或医源性的。PPROM的并发症包括早产、绒毛膜羊膜炎、新生儿败血症、肢体位置缺陷、呼吸窘迫综合征、肺发育不全、慢性肺病、脑室周围白质软化和脑室内出血。已采用了多种不同的封闭技术,旨在恢复抗感染的物理屏障并促进羊水的重新积聚。由于缺乏足够证据支持此类干预措施的安全性和有效性,目前不建议常规使用封闭剂。

目的

评估PPROM后封闭技术相互之间或与标准治疗(包括不使用封闭剂)相比,对孕产妇和新生儿结局的影响。

检索方法

我们检索了Cochrane妊娠和分娩组试验注册库(2016年5月30日)以及检索到的研究的参考文献列表。

选择标准

比较不同技术封闭早产胎膜早破的随机和半随机对照试验。整群随机试验和采用交叉设计的试验不符合本综述的纳入标准。当提供足够信息时,我们计划纳入摘要。

数据收集与分析

两位综述作者独立评估试验是否纳入并评估试验质量。两位综述作者独立提取数据。检查数据的准确性。

主要结果

我们纳入了两项研究(涉及141名女性,124名女性的数据)。我们认为这两项研究都存在高偏倚风险。由于纳入的研究检查了不同的干预措施(均与标准治疗相比)且报告的结局较少且不同,因此无法进行荟萃分析。一项研究比较了宫颈适配器(机械封闭),另一项研究检查了免疫性胎膜封闭剂。纳入的两项研究均未报告本综述感兴趣的主要结局——围产期死亡率。同样,本综述大多数次要的婴儿和孕产妇结局的数据也未报告。宫颈适配器(机械封闭)与标准治疗(一项研究,35名参与者的数据)未报告本综述的主要结局——围产期死亡率。本综述的婴儿或孕产妇次要结局中只有少数报告了数据。机械封闭组与标准治疗对照组在新生儿败血症发生率(风险比(RR)1.19,95%置信区间(CI)0.28至5.09(极低质量证据))或绒毛膜羊膜炎发生率(RR 1.19,95%CI 0.28至5.09(极低质量证据))方面没有明显差异。口服免疫性胎膜封闭剂与标准治疗(一项研究,94名参与者的数据)围产期死亡率(本综述的主要结局)或本综述大多数婴儿和孕产妇次要结局均无可用数据。与标准治疗相比,免疫性胎膜封闭剂与孕周小于37周的早产减少(RR 0.48,95%CI 0.34至0.68(极低质量证据))和新生儿死亡减少(RR 0.38,95%CI 0.19至0.75(极低质量证据))相关。然而,两组在新生儿败血症(RR 0.64,95%CI 0.28至1.46(极低质量证据))或呼吸窘迫综合征(RR 0.64,95%CI 0.28至1.46(极低质量证据))方面没有明显差异。

作者结论

没有足够证据评估PPROM封闭程序。没有与本综述主要结局(围产期死亡率)相关的数据,且纳入的两项研究未报告我们大多数婴儿和孕产妇次要结局的数据。有有限证据表明免疫性胎膜封闭剂与孕周小于37周的早产减少和新生儿死亡减少相关,但这些结果应谨慎解释,因为这基于一项小研究,偏倚风险高,且该干预措施尚未在其他研究中进行测试。尽管孕中期PPROM并不罕见,但关于封闭程序的益处和风险的已发表数据很少。这些研究大多是回顾性和队列研究,因此不能纳入我们的数据分析。本综述突出了该领域前瞻性随机试验的匮乏。现有证据在所述干预措施的有效性和安全性方面提供的信息有限。鉴于高质量数据匮乏,我们建议未来的研究工作集中于开展随机试验,评估那些仅在队列研究中进行过评估的有前景的干预措施(如羊膜贴片)的效果。未来试验应关注包括围产期死亡率、早产、新生儿死亡、呼吸窘迫综合征、新生儿败血症和发育迟缓等结局。还应评估孕产妇结局,包括败血症、分娩方式、住院时间和情绪健康。

相似文献

1
Sealing procedures for preterm prelabour rupture of membranes.
Cochrane Database Syst Rev. 2016 Jul 7;7(7):CD010218. doi: 10.1002/14651858.CD010218.pub2.
2
Amnioinfusion for chorioamnionitis.
Cochrane Database Syst Rev. 2016 Aug 24;2016(8):CD011622. doi: 10.1002/14651858.CD011622.pub2.
4
Different corticosteroids and regimens for accelerating fetal lung maturation for babies at risk of preterm birth.
Cochrane Database Syst Rev. 2022 Aug 9;8(8):CD006764. doi: 10.1002/14651858.CD006764.pub4.
5
Planned early birth versus expectant management (waiting) for prelabour rupture of membranes at term (37 weeks or more).
Cochrane Database Syst Rev. 2017 Jan 4;1(1):CD005302. doi: 10.1002/14651858.CD005302.pub3.
6
Immediate versus deferred delivery of the preterm baby with suspected fetal compromise for improving outcomes.
Cochrane Database Syst Rev. 2016 Jul 12;7(7):CD008968. doi: 10.1002/14651858.CD008968.pub3.
7
Interventions for treating genital Chlamydia trachomatis infection in pregnancy.
Cochrane Database Syst Rev. 2017 Sep 22;9(9):CD010485. doi: 10.1002/14651858.CD010485.pub2.
8
Oxytocin for preventing postpartum haemorrhage (PPH) in non-facility birth settings.
Cochrane Database Syst Rev. 2016 Apr 14;4(4):CD011491. doi: 10.1002/14651858.CD011491.pub2.
9
Techniques of monitoring blood glucose during pregnancy for women with pre-existing diabetes.
Cochrane Database Syst Rev. 2017 Jun 11;6(6):CD009613. doi: 10.1002/14651858.CD009613.pub3.
10
Intermittent auscultation (IA) of fetal heart rate in labour for fetal well-being.
Cochrane Database Syst Rev. 2017 Feb 13;2(2):CD008680. doi: 10.1002/14651858.CD008680.pub2.

引用本文的文献

2
Antenatal and intrapartum interventions for preventing cerebral palsy: an overview of Cochrane systematic reviews.
Cochrane Database Syst Rev. 2017 Aug 8;8(8):CD012077. doi: 10.1002/14651858.CD012077.pub2.

本文引用的文献

1
Amniopatch for iatrogenic rupture of the fetal membranes.
Prenat Diagn. 2011 Jul;31(7):661-6. doi: 10.1002/pd.2780. Epub 2011 Jun 8.
2
Update on procedure-related risks for prenatal diagnosis techniques.
Fetal Diagn Ther. 2010;27(1):1-7. doi: 10.1159/000271995. Epub 2009 Dec 24.
3
IGFBP-1 levels in cervicovaginal secretions before and after amniocentesis.
Gynecol Obstet Invest. 2009;67(1):9-13. doi: 10.1159/000150598. Epub 2008 Aug 6.
5
Fetoscopic surgery: encouraged by clinical experience and boosted by instrument innovation.
Semin Fetal Neonatal Med. 2006 Dec;11(6):398-412. doi: 10.1016/j.siny.2006.09.003. Epub 2006 Oct 20.
6
A histological study of fetoscopic membrane defects to document membrane healing.
Placenta. 2006 Apr-May;27(4-5):452-6. doi: 10.1016/j.placenta.2005.03.008. Epub 2005 Jun 13.
7
ASCORBIC ACID DEFICIENCY AND PREMATURE RUPTURE OF FETAL MEMBRANES.
Am J Obstet Gynecol. 1964 Mar 1;88:592-5. doi: 10.1016/0002-9378(64)90885-3.
8
Intrauterine infection and the development of cerebral palsy.
BJOG. 2003 Apr;110 Suppl 20:124-7. doi: 10.1016/s1470-0328(03)00063-6.
9
Preterm premature rupture of the membranes.
Obstet Gynecol. 2003 Jan;101(1):178-93. doi: 10.1016/s0029-7844(02)02366-9.
10
Intracervical fibrin sealants: a potential treatment for early preterm premature rupture of the membranes.
Am J Obstet Gynecol. 2001 Feb;184(3):368-73. doi: 10.1067/mob.2001.111796.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验